NexImmune, Inc. (NEXI)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.0001 (-50.00%)
Oct 6, 2025, 1:39 PM EDT
NexImmune Market Cap
NexImmune has a market cap or net worth of $139.00 as of October 7, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
139.00
Enterprise Value
-2.42M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 12, 2021, NexImmune's market cap has decreased from 545.88M to 139.00, a decrease of -100.00%. That is a compound annual growth rate of -96.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 139.00 | -99.91% |
| Dec 31, 2024 | 160.46K | -93.17% |
| Dec 29, 2023 | 2.35M | -62.95% |
| Dec 30, 2022 | 6.34M | -93.94% |
| Dec 31, 2021 | 104.70M | -80.82% |
| Feb 12, 2021 | 545.88M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 686.89M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 382.92M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 321.63M |
| American Oncology Network | 273.17M |
| Silence Therapeutics | 245.14M |